Heterozygous loss-of-function variants of MEIS2 cause a triad of palatal defects, congenital heart defects, and intellectual disability.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
02 2019
Historique:
received: 29 11 2017
accepted: 15 07 2018
revised: 03 07 2018
pubmed: 7 10 2018
medline: 10 5 2019
entrez: 7 10 2018
Statut: ppublish

Résumé

Deletions on chromosome 15q14 are a known chromosomal cause of cleft palate, typically co-occurring with intellectual disability, facial dysmorphism, and congenital heart defects. The identification of patients with loss-of-function variants in MEIS2, a gene within this deletion, suggests that these features are attributed to haploinsufficiency of MEIS2. To further delineate the phenotypic spectrum of the MEIS2-related syndrome, we collected 23 previously unreported patients with either a de novo sequence variant in MEIS2 (9 patients), or a 15q14 microdeletion affecting MEIS2 (14 patients). All but one de novo MEIS2 variant were identified by whole-exome sequencing. One variant was found by targeted sequencing of MEIS2 in a girl with a clinical suspicion of this syndrome. In addition to the triad of palatal defects, heart defects, and developmental delay, heterozygous loss of MEIS2 results in recurrent facial features, including thin and arched eyebrows, short alae nasi, and thin vermillion. Genotype-phenotype comparison between patients with 15q14 deletions and patients with sequence variants or intragenic deletions within MEIS2, showed a higher prevalence of moderate-to-severe intellectual disability in the former group, advocating for an independent locus for psychomotor development neighboring MEIS2.

Identifiants

pubmed: 30291340
doi: 10.1038/s41431-018-0281-5
pii: 10.1038/s41431-018-0281-5
pmc: PMC6336847
doi:

Substances chimiques

Homeodomain Proteins 0
MEIS2 protein, human 0
Transcription Factors 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

278-290

Subventions

Organisme : NHLBI NIH HHS
ID : UM1 HL098162
Pays : United States
Organisme : NHLBI NIH HHS
ID : UM1 HL098123
Pays : United States
Organisme : Department of Health
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : U01 HL131003
Pays : United States
Organisme : Wellcome Trust
ID : WT098051
Pays : United Kingdom
Organisme : NIH HHS
ID : S10 OD018522
Pays : United States
Organisme : NHLBI NIH HHS
ID : UM1 HL128761
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : UM1 HL128711
Pays : United States
Organisme : NHLBI NIH HHS
ID : UM1 HL098147
Pays : United States

Références

Am J Med Genet A. 2008 Aug 1;146A(15):1933-41
pubmed: 18561338
Cell. 2012 Sep 28;151(1):221-32
pubmed: 22981225
Dev Dyn. 2013 Jul;242(7):817-31
pubmed: 23559552
Genome Med. 2017 Sep 21;9(1):83
pubmed: 28934986
Am J Med Genet A. 2007 Jan 15;143A(2):172-8
pubmed: 17163532
BMC Dev Biol. 2015 Nov 06;15:40
pubmed: 26545946
Am J Med Genet A. 2014 Jul;164A(7):1622-6
pubmed: 24678003
Orphanet J Rare Dis. 2011 Apr 19;6:17
pubmed: 21504564
Science. 2015 Dec 4;350(6265):1262-6
pubmed: 26785492
Gene. 2015 Jul 1;565(1):146-9
pubmed: 25839933
Am J Hum Genet. 2009 Apr;84(4):524-33
pubmed: 19344873
Dev Neurosci. 2010 Jul;32(2):149-62
pubmed: 20523026
J Hum Genet. 2016 Sep;61(9):835-8
pubmed: 27225850
Am J Med Genet. 1993 Oct 1;47(5):679-82
pubmed: 8266995
Semin Cell Dev Biol. 2002 Dec;13(6):507-13
pubmed: 12468254
Taiwan J Obstet Gynecol. 2016 Apr;55(2):270-4
pubmed: 27125413
Am J Med Genet A. 2015 May;167A(5):1142-6
pubmed: 25712757
Am J Med Genet A. 2014 Aug;164A(8):1923-30
pubmed: 24733578
N Engl J Med. 2017 Jan 5;376(1):21-31
pubmed: 27959697
Nature. 2006 Nov 2;444(7115):110-4
pubmed: 17080092
Am J Hum Genet. 2015 Aug 6;97(2):302-10
pubmed: 26166480
Hum Genome Var. 2017 Jul 20;4:17029
pubmed: 28736618
Eur J Med Genet. 2008 Jul-Aug;51(4):368-72
pubmed: 18458017
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
Hum Mutat. 2013 Sep;34(9):1226-30
pubmed: 23766104
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
Am J Med Genet A. 2013 Dec;161A(12):3166-75
pubmed: 24214399
Nat Genet. 2007 Sep;39(9):1120-6
pubmed: 17704776
Am J Hum Genet. 2016 Oct 6;99(4):877-885
pubmed: 27666373
Am J Hum Genet. 2010 Nov 12;87(5):671-8
pubmed: 20950788
Lancet. 2015 Apr 4;385(9975):1305-14
pubmed: 25529582
Mech Dev. 2001 Apr;102(1-2):247-50
pubmed: 11287203
Am J Med Genet A. 2010 May;152A(5):1326-7
pubmed: 20425846
Sci Signal. 2013 Apr 02;6(269):pl1
pubmed: 23550210

Auteurs

Rosalind Verheije (R)

Center for Human Genetics, Catholic University Leuven, Leuven, Belgium.

Gabriel S Kupchik (GS)

Division of Medical Genetics, Infants and Children's Hospital of Brooklyn, Maimonides Medical Center, Brooklyn, NY, USA.

Bertrand Isidor (B)

CHU Nantes, Service de génétique médicale, Nantes, France.
INSERM UMR 1238, Sarcomes osseux et remodelage des tissus calcifiés, Université Bretagne Loire, Nantes, France.

Hester Y Kroes (HY)

Department of Medical Genetics, University Medical Center Utrecht, Utrecht, Netherlands.

Sally Ann Lynch (SA)

Departments of Clinical Genetics, Children's University Hospital Temple Street, Dublin, Ireland.

Lara Hawkes (L)

Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Spires Cleft Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Maja Hempel (M)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Bruce D Gelb (BD)

The Mindich Child Health and Development Institute and the Departments of Pediatrics and Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Jamal Ghoumid (J)

Service de Génétique Clinique, Hôpital Jeanne de Flandre, CHU Lille, Lille, France.

Guylaine D'Amours (G)

Service de génétique médicale, CHU Sainte-Justine, Département de Pédiatrie, Université de Montréal, Montréal, QC, Canada.

Kate Chandler (K)

Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Christèle Dubourg (C)

Laboratoire de Génétique Moléculaire, CHU Pontchaillou, Rennes, France.

Sara Loddo (S)

Laboratory of Medical Genetics, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.

Zeynep Tümer (Z)

Applied Human Molecular Genetics, Kennedy Center, Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Glostrup, Denmark.

Charles Shaw-Smith (C)

Institute of Biomedical & Clinical Science, University of Exeter Medical School, Exeter, UK.

Mathilde Nizon (M)

CHU Nantes, Service de génétique médicale, Nantes, France.

Michael Shevell (M)

Department of Pediatrics, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.

Evelien Van Hoof (E)

Center for Human Genetics, Catholic University Leuven, Leuven, Belgium.

Kwame Anyane-Yeboa (K)

Division of Clinical Genetics, Department of Pediatrics, Columbia University Medical Center, New York, NY, USA.

Gaetana Cerbone (G)

Division of Medical Genetics, "S.G. Moscati" Hospital, Avellino, Italy.

Jill Clayton-Smith (J)

Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Benjamin Cogné (B)

CHU Nantes, Service de génétique médicale, Nantes, France.

Pierre Corre (P)

Service de Stomatologie, CHU Nantes, Nantes, France.

Anniek Corveleyn (A)

Center for Human Genetics, Catholic University Leuven, Leuven, Belgium.

Marie De Borre (M)

Center for Human Genetics, Catholic University Leuven, Leuven, Belgium.

Tina Duelund Hjortshøj (TD)

Applied Human Molecular Genetics, Kennedy Center, Department of Clinical Genetics, Copenhagen University Hospital Rigshospitalet, Glostrup, Denmark.

Mélanie Fradin (M)

Service de Génétique Médicale, Centre de Reference Anomalies du Développement, CHU Rennes, Rennes, France.

Marc Gewillig (M)

Pediatric and Congenital Cardiology, UZ Leuven, Leuven, Belgium.

Elizabeth Goldmuntz (E)

Division of Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Greet Hens (G)

Department of Otorhinolaryngology-Head and Neck Surgery, University Hospitals Leuven, Leuven, Belgium.

Emmanuelle Lemyre (E)

Service de génétique médicale, CHU Sainte-Justine, Département de Pédiatrie, Université de Montréal, Montréal, QC, Canada.

Hubert Journel (H)

Service de Génétique Médicale, Centre de Reference Anomalies du Développement, CHU Rennes, Rennes, France.

Usha Kini (U)

Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Spires Cleft Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Fanny Kortüm (F)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Cedric Le Caignec (C)

CHU Nantes, Service de génétique médicale, Nantes, France.
INSERM UMR 1238, Sarcomes osseux et remodelage des tissus calcifiés, Université Bretagne Loire, Nantes, France.

Antonio Novelli (A)

Laboratory of Medical Genetics, Bambino Gesu Children's Hospital, IRCCS, Rome, Italy.

Sylvie Odent (S)

Service de Génétique Médicale, Centre de Reference Anomalies du Développement, CHU Rennes, Rennes, France.

Florence Petit (F)

Service de Génétique Clinique, Hôpital Jeanne de Flandre, CHU Lille, Lille, France.

Anya Revah-Politi (A)

Institute for Genomic Medicine, Columbia University Medical Center, New York, NY, USA.

Nicholas Stong (N)

Institute for Genomic Medicine, Columbia University Medical Center, New York, NY, USA.

Tim M Strom (TM)

Institute for Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Institute for Human Genetics, Technische Universitat Munchen, Munich, Germany.

Ellen van Binsbergen (E)

Department of Medical Genetics, University Medical Center Utrecht, Utrecht, Netherlands.

Koenraad Devriendt (K)

Center for Human Genetics, Catholic University Leuven, Leuven, Belgium.

Jeroen Breckpot (J)

Center for Human Genetics, Catholic University Leuven, Leuven, Belgium. Jeroen.Breckpot@uzleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH